Researchers at Johns Hopkins University School of Medicine have identified a subgroup of patients with necrotizing myopathy who have a novel autoantibody specificity that makes them potential ...

Peterson died from a rare immune disease, Immune-Mediated Necrotizing Myopathy (IMNM.) It’s a disease that causes severe ...

Argenx (ARGX) announced the decision to continue development of efgartigimod subcutaneous in the ongoing Phase 2/3 ALKIVIA study in adults with ...

Cabaletta Bio (CABA) announced new and updated clinical data on CABA-201 demonstrating the potential to achieve drug-free, compelling clinical ...